跳至主要内容
临床试验/NCT07292987
NCT07292987招募中不适用

Implementation and Evaluation of a Post-diagnostic Announcement Protocol at the CRMR RefeRet of the Quinze-Vingts National Ophthalmology Hospital

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年12月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
80
试验地点
1
主要终点
Patient Satisfaction via PREM at 12 months

研究概览

简要总结

This study explores whether adding early nurse-led and psychological support after the diagnosis of retinitis pigmentosa (RP) can improve patient experience and emotional well-being. RP is a rare, progressive eye disease often diagnosed after a long and difficult process, and receiving the diagnosis can be emotionally distressing.

Eighty newly diagnosed adults will be randomly assigned to either usual care or an enhanced pathway that includes early follow-up with a nurse, structured emotional monitoring, and a psychologist visit at six months.

The study aims to determine if this structured support improves patient satisfaction and reduces anxiety and depression compared with standard care.

详细描述

Retinitis pigmentosa (RP) is a rare genetic disease causing progressive vision loss. The announcement of diagnosis is a key moment that may trigger anxiety or depression, yet post-diagnostic care in ophthalmology often remains limited to medical information.

This prospective, monocentric, randomized study at the Quinze-Vingts National Ophthalmology Hospital tests a structured post-diagnostic support pathway that combines early nurse-led follow-up and systematic psychological support.

Eighty newly diagnosed patients aged 18-65 will be randomized into two parallel groups. The experimental group will receive early nurse consultations at 15 days and 6 months, psychological follow-up at 6 months, and repeated HADS assessments. The control group will receive usual care.

The primary outcome is patient satisfaction at 12 months (PREM). Secondary outcomes include changes in anxiety and depression (HADS) and feasibility feedback from nursing staff (RETEX).

Findings will inform the design of sustainable, multidisciplinary care models for rare eye diseases.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with retinitis pigmentosa (RP) and followed at the Quinze-Vingts Rare Eye Disease Center, with diagnosis made after the project begins
  • Aged 18 to 65 years
  • Male or female
  • French-speaking
  • Have a phone number
  • Reside in France

排除标准

  • Pregnant women
  • Participants enrolled in a therapeutic clinical trial within the past 12 months
  • Individuals deprived of liberty by judicial or administrative decision
  • Adults under legal protection or unable to provide informed consent
  • Individuals with other medical conditions or taking treatments that could interfere with study evaluations

研究组 & 干预措施

Usual care group

Active Comparator

干预措施: Usual Care (Behavioral)

Enhanced care group

Experimental

干预措施: Enhanced post-diagnostic support (Behavioral)

结局指标

主要结局

Patient Satisfaction via PREM at 12 months

时间窗: 12 months

Difference in patient satisfaction via PREM (Patient Reported Experience Measure) at 12 months between the two arms. Items were rated on a 5-point Likert scale ranging from 1 (extremely worse than expected) to 5 (better than expected). Higher scores indicate a better perceived quality of care and psychological support.

次要结局

  • Psychological impact after post-diagnostic support via HADS(15 days, 6 months and 12 months after diagnosis)
  • Feasibility and staff experience of implementing enhanced post-diagnostic support via RETEX and observation log(15 days, 6 months and 12 months after diagnosis)

研究者

发起方
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验